Ecstasy (MDMA): a review of its possible persistent psychological effects

Abstract. Rationale: Recreational use of "ecstasy" (3,4-methylenedioxymethamphetamine; MDMA) has become increasingly widespread. Until recently, however, little was known about the possible persistent psychological effects of extensive use of this drug. Objective: The aim of the present review is to evaluate recent empirical evidence concerning the persistent psychological sequelae of recreational ecstasy use. Methods: The methodologies of open trial studies of recreational ecstasy users are evaluated and reports of the presence or absence of persistent psychological problems are related to the extent of past exposure to ecstasy. Results: There is growing evidence that chronic, heavy, recreational use of ecstasy is associated with sleep disorders, depressed mood, persistent elevation of anxiety, impulsiveness and hostility, and selective impairment of episodic memory, working memory and attention. There is tentative evidence that these cognitive deficits persist for at least 6 months after abstinence, whereas anxiety and hostility remit after a year of abstinence. The possibility that some of these psychological problems are caused by ecstasy-induced neurotoxicity is supported by preclinical evidence of MDMA-induced neurotoxicity and behavioural deficits, evidence of depleted serotonin in heavy ecstasy users, and by dose-response relationships between the extent of exposure to ecstasy and the severity of cognitive impairments. Conclusions: An increasing number of young, heavy ecstasy users are at significant risk of persistent cognitive impairments and disturbances of affect and personality. Some of these problems may remit after abstinence, but residual neurotoxicity and decline of serotonergic function with age may result in recurrent psychopathology and premature cognitive decline.

[1]  J. V. van Gerven,et al.  Cognitive performance and serotonergic function in users of ecstasy , 2000, Psychopharmacology.

[2]  P. McGuire,et al.  Diversity of Psychopathology Associated with use of 3,4-Methylenedioxymethamphetamine (‘Ecstasy’) , 1994, British Journal of Psychiatry.

[3]  A. García-Osta,et al.  Differential Regulation by Methylenedioxymethamphetamine of 5‐Hydroxytryptamine1A Receptor Density and mRNA Expression in Rat Hippocampus, Frontal Cortex, and Brainstem: The Role of Corticosteroids , 1997, Journal of neurochemistry.

[4]  M. Gervin,et al.  Psychosis and recreational use of MDMA (“Ecstasy”) , 1993, Irish Journal of Psychological Medicine.

[5]  S. Peroutka,et al.  Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. , 1988, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[6]  Georg Juckel,et al.  Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: A new hypothesis , 1993, Biological Psychiatry.

[7]  E. D. De Souza,et al.  3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. , 1987, The Journal of pharmacology and experimental therapeutics.

[8]  K. Faull,et al.  Monoamine metabolites in the cerebrospinal fluid of recreational users of 3,4-methylenedimethoxymethamphetamine (MDMA: Ecstasy , 1987 .

[9]  J. Langston,et al.  Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observations a , 1990, Annals of the New York Academy of Sciences.

[10]  G. Gerra,et al.  Long-lasting effects of (±)3,4-methylene-dioxymethamphetamine (Ecstasy) on serotonin system function in humans , 2000, Biological Psychiatry.

[11]  L. Seiden,et al.  Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys , 1989, Brain Research.

[12]  M. Mishkin Memory in monkeys severely impaired by combined but not by separate removal of amygdala and hippocampus , 1978, Nature.

[13]  U. McCann,et al.  Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine ('ecstasy') in recreational users. , 1991, Journal of clinical psychopharmacology.

[14]  P. Kelly Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) , 2000, Journal of neurology, neurosurgery, and psychiatry.

[15]  Andrew C. Parrott,et al.  Ecstasy (MDMA) in Recreational Users: Self‐Reported Psychological and Physiological Effects , 1997 .

[16]  P. McGuire Long term psychiatric and cognitive effects of MDMA use. , 2000, Toxicology letters.

[17]  Klaus P. Ebmeier,et al.  Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (‘ecstasy’) users , 1999, British Journal of Psychiatry.

[18]  L S Seiden,et al.  Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. , 1987, The Journal of pharmacology and experimental therapeutics.

[19]  R. Cohen Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; “Ecstasy”) , 1996, Biological Psychiatry.

[20]  J. Downing The psychological and physiological effects of MDMA on normal volunteers. , 1986, Journal of psychoactive drugs.

[21]  G. Gerra,et al.  Serotonergic function after (±)3,4‐methylene-dioxymethamphetarnine (‘Ecstasy’) in humans , 1998, International clinical psychopharmacology.

[22]  Z. Szabo,et al.  In vivo detection of short‐ and long‐term MDMA neurotoxicity—a positron emission tomography study in the living baboon brain , 1998, Synapse.

[23]  A. Hunter Serotonergic involvement in learning and memory. , 1989, Biochemical Society transactions.

[24]  Peroutka Sj Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine (MDMA, "ecstasy") on an undergraduate campus. , 1987 .

[25]  M. Conner,et al.  Validating the Consumption of MDMA (3,4-Methylenedioxymethamphetamine in an examination of the behavioural effects of "ecstasy" amongst recreational users. , 1999 .

[26]  G. Aghajanian,et al.  Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. , 1990, Archives of general psychiatry.

[27]  R. Peveler,et al.  Psychiatric complications of 'Ecstasy' use , 1994, Journal of psychopharmacology.

[28]  Z. Szabo,et al.  Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings , 1998, The Lancet.

[29]  S. Peroutka Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine (MDMA, "ecstasy") on an undergraduate campus. , 1987, The New England journal of medicine.

[30]  R. Cohen Subjective reports on the effects of the MDMA (‘ecstasy’) experience in humans , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[31]  L S Seiden,et al.  Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. , 1996, NIDA research monograph.

[32]  A. Parrott,et al.  Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users. , 2000, Drug and alcohol dependence.

[33]  G. Battaglia,et al.  Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[34]  M. Colado,et al.  The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (`ecstasy') , 1998, Neuropharmacology.

[35]  J. Richards,et al.  Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies. , 1996, The Journal of pharmacology and experimental therapeutics.

[36]  J. Krystal,et al.  Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations. , 1989, Archives of general psychiatry.

[37]  A. Forsyth,et al.  Places and patterns of drug use in the Scottish dance scene. , 1996, Addiction.

[38]  D Lehmann,et al.  Mood state and brain electric activity in Ecstasy users , 2000, Neuroreport.

[39]  R. Buchert,et al.  Ecstasy – long-term effects on the human central nervous system revealed by positron emission tomography , 1999, British Journal of Psychiatry.

[40]  U. McCann,et al.  (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals , 2000, Neuropsychobiology.

[41]  R. Walsh,et al.  Phenomenology and Sequelae of 3,4-Methylenedioxymethamphetamine Use , 1992, The Journal of nervous and mental disease.

[42]  D. Wechsler A Standardized Memory Scale for Clinical Use , 1945 .

[43]  D. Murphy,et al.  Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users , 1999, Psychopharmacology.

[44]  H. Nelson A Modified Card Sorting Test Sensitive to Frontal Lobe Defects , 1976, Cortex.

[45]  C. Ballard,et al.  Psychiatric sequelae of MDMA (ecstasy) and related drugs , 1994, Irish Journal of Psychological Medicine.

[46]  K. Dantendorfer,et al.  Panic disorder induced by large doses of 3,4-methylenedioxymethamphetamine resolved by paroxetine. , 1998, Journal of clinical psychopharmacology.

[47]  G. Ricaurte,et al.  Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[48]  J. Fisk,et al.  Working memory deficits in current and previous users of MDMA ('ecstasy'). , 2000, British journal of psychology.

[49]  A. Meneses,et al.  Modification of 8-OH-DPAT effects on learning by manipulation of the assay conditions. , 1994, Behavioral and neural biology.

[50]  H J Eysenck,et al.  Sensation seeking in England and America: cross-cultural, age, and sex comparisons. , 1978, Journal of consulting and clinical psychology.

[51]  A D Baddeley,et al.  Subjective memory assessment and test performance in elderly adults. , 1986, Journal of gerontology.

[52]  T. Mieczkowski,et al.  Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse. , 1997, Forensic science international.

[53]  P. Mcguire,et al.  Chronic paranoid psychosis after misuse of MDMA ("ecstasy") , 1991, BMJ.

[54]  N. Solowij,et al.  Ecstasy use in Australia: patterns of use and associated harm. , 1999, Drug and alcohol dependence.

[55]  J. Langston,et al.  Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration , 1988, Brain Research.

[56]  Y. Shaham,et al.  Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans , 1994, Neuropsychopharmacology.

[57]  J. Richards,et al.  Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: Synaptosomal uptake and tissue concentrations. , 1996, The Journal of pharmacology and experimental therapeutics.

[58]  Josephine Spiller,et al.  Drug misuse declared in 1996: Latest results from the British crime survey: Home office research study 172 , 1997 .

[59]  Thomas Fahy,et al.  Flashbacks following MDMA , 1992, British Journal of Psychiatry.

[60]  C. Robert Cloninger A systematic method for clinical description and classification of personality variants. A proposal. , 1987, Archives of general psychiatry.

[61]  D. Olton,et al.  Neurotransmitters and memory: role of cholinergic, serotonergic, and noradrenergic systems. , 1987, Behavioral neuroscience.

[62]  T. Shallice Specific impairments of planning. , 1982, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[63]  U. McCann,et al.  Memory impairment in abstinent MDMA ("Ecstasy") users , 1998, Neurology.

[64]  L. Seiden,et al.  Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence. , 1997, JAMA.

[65]  M. Bourin,et al.  3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans , 1999, Neuroscience & Biobehavioral Reviews.

[66]  U. McCann,et al.  Persistent effects of (+/- )3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on human sleep. , 1993, Sleep.

[67]  H. Curran,et al.  Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low. , 1997, Addiction.

[68]  A. Cook Ecstasy (MDMA): alerting users to the dangers. , 1995, Nursing times.

[69]  S. Pallanti,et al.  MDMA (Ecstasy) precipitation of panic disorder , 1992, Biological Psychiatry.

[70]  A. Buss,et al.  An inventory for assessing different kinds of hostility. , 1957, Journal of consulting psychology.

[71]  C. Hyde,et al.  ‘Ecstasy’ Psychosis and Flashbacks , 1991, British Journal of Psychiatry.

[72]  A. Lees,et al.  Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits , 1998, Journal of psychopharmacology.

[73]  T. Ernst,et al.  Cerebral 1H MRS alterations in recreational 3,4‐methylenedioxymethamphetamine (MDMA, “ecstasy”) users , 1999, Journal of magnetic resonance imaging : JMRI.

[74]  T. Robinson,et al.  Effects of Cortical Serotonin Depletion Induced by 3,4-Methylenedioxymethamphetamine (MDMA) on Behavior, Before and After Additional Cholinergic Blockade , 1993, Neuropsychopharmacology.

[75]  F. Graeff Role of 5-HT in Defensive Behavior and Anxiety , 1993, Reviews in the neurosciences.

[76]  H. Klee Amphetamine Misuse: International Perspectives on Current Trends , 1997 .

[77]  M. Spoont Modulatory role of serotonin in neural information processing: implications for human psychopathology. , 1992, Psychological bulletin.

[78]  O. Hornykiewicz Dopamine (3-hydroxytyramine) and brain function. , 1966, Pharmacological reviews.

[79]  S. Peroutka,et al.  Neurochemistry and Neurotoxicity of 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”) , 1990, Journal of neurochemistry.

[80]  P. McGuire,et al.  Toxic effect of MDMA on brain serotonin neurons , 1999, The Lancet.

[81]  Patrick J. O'Donnell,et al.  Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence , 1999, Psychopharmacology.

[82]  M. Morgan Memory deficits associated with recreational use of “ecstasy” (MDMA) , 1999, Psychopharmacology.

[83]  S. Butcher,et al.  Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat , 1999, Psychopharmacology.

[84]  Tommy Cammock,et al.  Development of a More Reliable Version of the Matching Familiar Figures Test. , 1978 .

[85]  P. D. Cohen,et al.  Licit and illicit drug use in Amsterdam III: developments in drug use 1987 - 1997 / Manja D. Abraham, Peter D.A. Cohen, Roelf-Jan Van Til, & Marieke P.S. Langemeijer , 2000 .

[86]  A. Parrott,et al.  Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance , 1998, Psychopharmacology.

[87]  W. Hall,et al.  Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug. , 1992, British journal of addiction.

[88]  U. McCann,et al.  3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans. , 1994, Addiction.

[89]  F. Benazzi,et al.  Psychiatric illness associated with "ecstasy" , 1991, The Lancet.

[90]  M. Morgan Recreational Use of “Ecstasy” (MDMA) Is Associated with Elevated Impulsivity , 1998, Neuropsychopharmacology.

[91]  P Bech,et al.  The Hamilton Depression Scale , 1981, Acta psychiatrica Scandinavica.

[92]  Jörg Daumann,et al.  High Intensity Dependence of Auditory Evoked Dipole Source Activity Indicates Decreased Serotonergic Activity in Abstinent Ecstasy (MDMA) Users , 2000, Neuropsychopharmacology.

[93]  M. Sarter,et al.  Involvement of the amygdala in learning and memory: a critical review, with emphasis on anatomical relations. , 1985, Behavioral neuroscience.

[94]  B. Yamamoto,et al.  The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. , 1988, European journal of pharmacology.

[95]  F. Schifano,et al.  MDMA (“ecstasy”) abuse: Psychopathological features and craving for chocolate: A case series , 1994, Biological Psychiatry.

[96]  L. Itti,et al.  Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study , 2000, Psychiatry Research: Neuroimaging.

[97]  C. J. Schmidt,et al.  Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. , 1987, The Journal of pharmacology and experimental therapeutics.

[98]  G. Battaglia,et al.  MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons , 1988, Pharmacology Biochemistry and Behavior.

[99]  E. Coccaro Central Serotonin and Impulsive Aggression , 1989, British Journal of Psychiatry.

[100]  J. Spatt,et al.  A pure amnestic syndrome after MDMA ("ecstasy") ingestion. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[101]  G. Ricaurte,et al.  Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. , 1992, The Journal of pharmacology and experimental therapeutics.

[102]  U. McCann,et al.  Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users: a controlled study , 1999, Psychopharmacology.

[103]  F. Schifano Chronic atypical psychosis associated with MDMA ("ecstasy") abuse , 1991, The Lancet.

[104]  W. Slikker,et al.  Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys. , 1995, Neurotoxicology and teratology.

[105]  Cloninger Cr A systematic method for clinical description and classification of personality variants: A proposal. , 1987 .

[106]  J. Krystal,et al.  Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function? , 1992, The American journal of drug and alcohol abuse.

[107]  M. Colado,et al.  5‐HT loss in rat brain following 3, 4‐methylenedioxymethamphetamine (MDMA), p‐chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine , 1993, British journal of pharmacology.

[108]  A. Schiff General Health Questionnaire , 1978, British Journal of Psychiatry.

[109]  D. E. Nichols,et al.  Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes. , 1982, Journal of medicinal chemistry.

[110]  R. Hammersley,et al.  Patterns of ecstasy use by drug users , 1999 .

[111]  G. Ricaurte,et al.  Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery , 1999, The Journal of Neuroscience.

[112]  Gerald L. Brown,et al.  Aggression in Humans Correlates With Cerebrospinal , 1979 .

[113]  Z. Kruk,et al.  Direct effects of 3,4‐methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphé nucleus slices , 2000, Synapse.

[114]  M. Conner,et al.  Contents of "ecstasy" , 1995, The Lancet.

[115]  F. Vollenweider,et al.  Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers , 1998, Neuropsychopharmacology.

[116]  R. Noyes,et al.  Relationship of generalized anxiety symptoms to urinary 5-hydroxyindoleacetic acid and vanillylmandelic acid , 1995, Psychiatry Research.

[117]  Seiden Ls,et al.  Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. , 1996 .

[118]  J. Cummings,et al.  Frontal-subcortical circuits and human behavior. , 1993, Journal of psychosomatic research.

[119]  J. T. Coull,et al.  Tryptophan depletion in normal volunteers produces selective impairments in learning and memory , 1994, Neuropharmacology.

[120]  Peter La Cour,et al.  Rivermead Behavioural Memory Test , 1990 .

[121]  F. Schifano,et al.  MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients. , 1998, Drug and alcohol dependence.

[122]  W. van den Brink,et al.  Memory disturbances in ”Ecstasy” users are correlated with an altered brain serotonin neurotransmission , 2000, Psychopharmacology.

[123]  G. Greer,et al.  Subjective reports of the effects of MDMA in a clinical setting. , 1986, Journal of psychoactive drugs.